Media Room
Explore our latest press releases, announcements, and updates on groundbreaking immunotherapy research.
For media inquiries, please contact us at [email protected].
-
Media Room Article
SITC and CRI Launch Annual Collaboration Bringing the Prestigious CRI William B. Coley Award Lecture to the SITC Annual Meeting
NK cell pioneer Éric Vivier, DVM, PhD, to deliver the inaugural lecture at SITC 2026 New York,… -
Media Room Article
Cancer Research Institute awards largest-ever annual grant total amid federal funding cuts — 93 awards totaling $37 million
NEW YORK, NY — The Cancer Research Institute (CRI) today announced its largest-ever annual grantmaking — 93… -
Media Room Article
First-Ever Treatments, Faster Paths to Approval, and a Shift in Global Drug Development Define the State of Cancer Immunotherapy in 2025, New Report Finds
Cancer Research Institute’s (CRI) annual Cancer Immunotherapy Insights & Impact report tracks 13 new FDA approvals and… -
Media Room Article
Kenneth M. Murphy, MD, PhD, Recognized With the 2026 AACR-CRI Lloyd J. Old Award in Cancer Immunology
SAN DIEGO – The American Association for Cancer Research (AACR)-Cancer Research Institute (CRI) Lloyd J. Old Award… -
Media Room Article
Multi-Organization Partnership Announces $2.5 Million for Aging & Cancer Research
Awards follow recent launch of the Samuel Waxman Aging & Cancer Institute, an affiliate of The Mark… -
Media Room Article
Israel Cancer Research Fund and Cancer Research Institute Announce Co-Funding of Grant to Address Immunotherapy Resistance in Melanoma
Research led by Asaf Madi, PhD, of Tel Aviv University could make TIL therapy more reliable and… -
Media Room Article
CRI Discovery Engine Inaugurates New Chapter in Immunotherapy, Creating the First-of-its-Kind AI-Ready Database
The Cancer Research Institute, in collaboration with 10x Genomics (NASDAQ: TXG), Stanford University School of Medicine, the… -
Media Room Article
Cancer Research Institute Names 26 New Postdoctoral Fellows
New York, NY – The Cancer Research Institute (CRI) is pleased to announce the Winter 2025 Class… -
Media Room Article
CRI Launches Pioneering Phase 2/3 Trial Using Labcorp Liquid Biopsy to Guide Precision Immunotherapy for Lung Cancer
NEW YORK, NY – The Cancer Research Institute (CRI) is pleased to announce the enrollment of the…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.